Throughout the coronavirus 2019 (COVID-19)
crisis, much attention has been devoted to the fraught question of how
to allocate intensive care unit (ICU) beds and mechanical ventilators if
the supply of these resources is insufficient to provide them to all
patients considered to be in need. Contemplating such tragic choices
naturally conjures thoughts that we might have avoided these dilemmas by
rapidly manufacturing new beds and ventilators at the first sign of a
looming pandemic, or by rapidly converting existing beds and machines
such that they could be used to expand the supply of critical care
resources. These ideas stem from the natural human heuristic and
conventional clinical ethos to mount unstinting effort toward saving the
lives of those who fall ill. These views are also psychologically
reinforced by the instinct to deploy aggressive medical technology to
win the “war” against the pandemic.
Indeed, the instinct to save the lives of the desperately ill, which exemplifies the “rule of rescue” (1),
is so intuitively powerful as to make it hard for humans to even
consider competing approaches. No one would condone a response to the
COVID-19 pandemic that did not include using the nation’s full supply of
critical care resources. However, the drive to build even more beds and
ventilators will do more to assuage public anxiety and outrage than to
reduce overall mortality, owing to both the poor outcomes among patients
with COVID-19 receiving mechanical ventilation and the diversion of
clinical workforces.
We argue that supply-side investments in
critical care in the midst of the pandemic would not substantially
improve population health in the short term and would worsen it in the
long term. As psychologically disruptive as it may be to consider not
expanding the critical care supply, such expansions would magnify the
already considerable skew of U.S. health care toward intensive care. We
further argue that even modest improvements in public health measures,
such as physical distancing (which might be promoted by infomercials
featuring sports or movie stars) and training more health care workers
to become expert in serious illness communication, would be more
effective than investments in critical care for improving short-term
population health.
Before COVID-19, the United States had more ICU beds and ventilators per capita than nearly any other country (2).
Indeed, an assessment of ICU occupancy and ventilator use revealed that
during noncrisis times, the United States has a glut of critical care
resources. In any given hour, only two thirds of ICU beds are occupied
and only one third are occupied by patients receiving mechanical
ventilation (3).
Although these numbers have been starkly different during the COVID-19
crisis, they highlight our substantial existing capacity to care for
those most likely to benefit from critical care.
As a result of this extant capacity, adding
ventilators and ICU beds would make critical care delivery less
efficient. Indeed, many studies have shown that when ICU beds are tight,
critical care is increasingly allocated to patients who benefit from
it, without increasing overall mortality (4–6).
Building more beds and ventilators would offset these efficiencies of
scarcity, increasing the already high mortality rates observed among
patients with COVID-19 who require mechanical ventilation (7). Although the total number of survivors might increase to an extent, so too would the burden of chronic critical illness.
The second reason that building more ICU beds
and ventilators will not deliver the hoped-for life savings is that they
are not the scarcest resources during the current pandemic. Most
projections indicate that ward beds and healthy critical care clinicians
will be more scarce than ICU beds or ventilators (8).
Thus, expansions to the ventilator supply may carry adverse
consequences for population health by requiring the redeployment of
non–critical care clinicians and beds, such that non–critically ill
patients may become critically ill and even die.
Such workforce redeployment reveals a third
reason to doubt the benefits of increasing critical care capacity: the
adverse consequences for clinician effectiveness and well-being.
Although building beds and ventilators may prevent the moral distress
that certain clinicians would otherwise feel in having to make
life-or-death choices about allocation, redeployment would likely
increase burnout among clinicians who are unaccustomed to working in
critical care environments. Asking physicians who have not contemplated a
ventilator since medical school to manage the sickest ventilated
patients, particularly without adequate personal protective equipment,
could adversely affect the long-term health of the clinical workforce.
Fourth, every dollar spent building more ICU
beds and ventilators would save more lives if instead spent on more
testing for severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), contact tracing, and personal protective equipment, or on
promoting adherence to physical distancing. Indeed, using the COVID-19
Hospital Impact Model for Epidemics (8),
we projected that even a doubling of the ventilator supply would not
save as many lives as a 40% decrease in physical contact. And the sooner
in a region’s epidemic trajectory such policies were implemented, the
greater the benefit of distancing, and the less the benefit of
ventilator production.
Other, less obvious initiatives might also yield
greater benefits to short-term population health. For example,
palliative care clinicians and others with excellent skills in serious
illness communication and symptom management are among the scarcest of
all health care resources (9).
Thus, COVID-19 leads us to utilize our preexisting glut of critical
care resources, but it also magnifies the preexisting shortage of
palliative care clinicians. Although expanding the palliative care
workforce will not save lives, it may offer a societal investment
superior to that of critical care expansion, given the resultant
benefits in quality of life for patients and their family caregivers.
Finally, in a nation in which nearly 1% of gross
domestic product is already allocated to critical care, further growth
should be approached with extreme reticence. History suggests that any
COVID-19–induced expansions to the critical care supply may
unfortunately be hard to reverse once the pandemic ends. Supply-induced
demand—or, “if you build it, they will come”—was a hallmark of U.S.
critical care well before COVID-19 (10).
Having experienced this pandemic, we will find it difficult to shrink
the critical care supply for fear of being underprepared for the next
pandemic.
Our natural moral reasoning precludes us from
withholding available critical care, even from patients with remote
chances of benefiting from it, and the same reasoning motivates us to
expand critical care during times of need. But even if building more ICU
beds and ventilators neither crowded out opportunities for other more
effective initiatives nor exacerbated critical care excesses in the
future, it would ultimately represent the triumph of deeply human
instincts over optimal policy.
References
-
Jonsen AR. Bentham in a box: technology assessment and health care allocation. Law Med Health Care. 1986;14:172-4. [PMID: 3645228]
-
Wunsch H, Angus DC, Harrison DA, et al. Variation in critical care services across North America and Western Europe. Crit Care Med. 2008;36:2787-93, e1-9. [PMID: 18766102] doi:10.1097/CCM.0b013e318186aec8
-
Wunsch H, Wagner J, Herlim M, et al. ICU occupancy and mechanical ventilator use in the United States. Crit Care Med. 2013;41:2712-9. [PMID: 23963122] doi:10.1097/CCM.0b013e318298a139
-
Wagner J, Gabler NB, Ratcliffe SJ, et al. Outcomes among patients discharged from busy intensive care units. Ann Intern Med. 2013;159:447-55. [PMID: 24081285] doi:10.7326/0003-4819-159-7-201310010-00004
-
Wagner J, Halpern SD. Deferred admission to the intensive care unit: rationing critical care or expediting care transitions? Arch Intern Med. 2012;172:474-6. [PMID: 22412077] doi:10.1001/archinternmed.2012.114
-
Anesi GL, Admon AJ, Halpern SD, et al. Understanding irresponsible use of intensive care unit resources in the USA. Lancet Respir Med. 2019;7:605-612. [PMID: 31122898] doi:10.1016/S2213-2600(19)30088-8
-
Richardson S, Hirsch JS, Narasimhan M, et al; Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020. [PMID: 32320003] doi:10.1001/jama.2020.6775
-
Weissman GE, Crane-Droesch A, Chivers C, et al. Locally informed simulation to predict hospital capacity needs during the COVID-19 pandemic. Ann Intern Med. 2020. [PMID: 32259197] doi:10.7326/M20-1260
-
Courtright KR, Cassel JB, Halpern SD. A research agenda for high-value palliative care. Ann Intern Med. 2018;168:71-72. [PMID: 29132161] doi:10.7326/M17-2164
-
Gooch RA, Kahn JM. ICU bed supply, utilization, and health care spending: an example of demand elasticity. JAMA. 2014;311:567-8. [PMID: 24408679] doi:10.1001/jama.2013.283800
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.